APA (7th ed.) Citation

Brown, J. R., Moslehi, J., O’Brien, S., Ghia, P., Hillmen, P., Cymbalista, F., . . . Burger, J. A. (2017). Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials. Haematologica (Roma), 102(10), 1796-1805. https://doi.org/10.3324/haematol.2017.171041

Chicago Style (17th ed.) Citation

Brown, Jennifer R., et al. "Characterization of Atrial Fibrillation Adverse Events Reported in Ibrutinib Randomized Controlled Registration Trials." Haematologica (Roma) 102, no. 10 (2017): 1796-1805. https://doi.org/10.3324/haematol.2017.171041.

MLA (9th ed.) Citation

Brown, Jennifer R., et al. "Characterization of Atrial Fibrillation Adverse Events Reported in Ibrutinib Randomized Controlled Registration Trials." Haematologica (Roma), vol. 102, no. 10, 2017, pp. 1796-1805, https://doi.org/10.3324/haematol.2017.171041.